Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson’s disease: the ADepT-PD RCT pilot

Background There is insufficient evidence on the effectiveness of different antidepressants in Parkinson’s disease. This trial was commissioned to provide robust evidence regarding the effectiveness of a tricyclic and a selective serotonin reuptake inhibitor on depression in people with Parkinson’s...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anette Schrag, Camille Carroll, Glyn Lewis, Marc Serfaty, Gordon Duncan, Sophie Molloy, John Whipps, Blair McLennan, Jing Yi (Jessica) Weng, Rachael M Hunter, Caroline S Clarke, Nicholas Freemantle, Andrew Embleton-Thirsk
Formato:	Artigo
Idioma:	Inglês
Publicado em:	NIHR Journals Library 2025-11-01
coleção:	Health Technology Assessment
Assuntos:	parkinson’s disease depression randomised controlled trial escitalopram nortriptyline placebo
Acesso em linha:	https://doi.org/10.3310/HFDO7575
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!